The mere notion of the US government supporting any policies that might encourage pharmaceutical patents to be ignored would have seemed inconceivable only 18 m 17 May 2021
US pharma major AbbVie has answered back in its latest row over Humira (adalimumab), the inflammatory diseases drug that it continues to sell without competitio 14 May 2021
To the surprise of many, the US Government has backed a World Trade Organization (WTO) proposal to disclaim certain intellectual property (IP) rights to coronav 6 May 2021
Nearly 18 months on from Enzyvant’s receipt of a Complete Response Letter (CRL) relating to its initial Biologics Licensing Application (BLA) for RVT-802, the c 28 April 2021
As anticipated, the European Union launched a legal action against AstraZeneca in the Belgian courts on Friday, alleging the British firm failed to live up to i 27 April 2021
The government must support a patent waiver for COVID-19 vaccines and treatments to protect the UK’s own vaccination program, according to public health experts 16 April 2021
The Brazilian Supreme Court of Justice is expected to deliver a potentially groundbreaking verdict on the constitutionality of a provision in the country’s inte 6 April 2021
In the UK, a tribunal has upheld a finding from the country’s antitrust regulator, the Competition and Markets Authority (CMA), which found that the wholesaler 25 February 2021
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.